PACS Group (NYSE:PACS) Stock: Insider Jason Hulse Murray Sells 68,917 Shares

PACS Group, Inc. (NYSE:PACS) CEO Jason Murray sold 68,917 shares of the business’s stock in a transaction dated Friday, October 23rd. The stock was sold at an average price of $48.60, for a total value of $3,349,366.20. Following the transaction, the chief executive officer owned 54,188,200 shares of the company’s stock, valued at approximately $2,633,546,520. The trade was a 0.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Hulse Murray also recently made the following trade(s):

• On Thursday, October 22nd, Jason Murray sold 13,696 shares of PACS Group stock. The shares were sold at an average price of $47.55, for a total value of $651,244.80.
• On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The shares were sold at an average price of $47.62, for a total value of $314,768.20.
• On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total value of $1,785,779.05.
• On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The stock was sold at an average price of $47.57, for a total transaction of $77,063.40.
• On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total transaction of $402,875.82.
• On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total transaction of $5,201,354.45.
• On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The stock was sold at an average price of $45.00, for a total transaction of $10,440.00.
• On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total transaction of $30,458.16.
• On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The stock was sold at an average price of $43.09, for a total transaction of $1,550,162.75.
• On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The stock was sold at an average price of $42.66, for a total transaction of $1,033,395.84.

PACS Group Price Performance

NYSE:PACS traded up $1.27 during midday trading on Monday, hitting $48.91. The company had a trading volume of 1,093,217 shares, compared to its average volume of 844,852. The company has a market capitalization of $7.74 billion, a PE ratio of 25.34, a P/E/G ratio of 1.49 and a beta of -0.08. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. PACS Group, Inc. has a 52-week low of $10.31 and a 52-week high of $49.78. The stock’s fifty day moving average price is $43.85 and its 200-day moving average price is $39.65.

PACS Group (NYSE:PACS) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.09. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. PACS Group had a return on equity of 29.55% and a net margin of 4.85%. As a group, research analysts expect that PACS Group, Inc. will post 2.13 earnings per share for the current year.

Analyst Upgrades and Downgrades

PACS has been the subject of a number of recent research reports. Oppenheimer boosted their price objective on shares of PACS Group from $48.00 to $57.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Truist Financial set a $62.00 target price on shares of PACS Group in a research report on Wednesday, September 2nd. Zacks Research downgraded shares of PACS Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 9th. JPMorgan Chase & Co. upped their price target on shares of PACS Group from $47.00 to $58.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. Finally, Royal Bank Of Canada raised their price objective on PACS Group from $52.00 to $57.00 and gave the company an “outperform” rating in a research note on Thursday, August 6th. Five investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, PACS Group presently has an average rating of “Moderate Buy” and a consensus price target of $58.80.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Financial Management Professionals Inc. increased its stake in shares of PACS Group by 54.9% in the second quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after buying an additional 235 shares during the period. GK Wealth Management LLC purchased a new stake in PACS Group during the 3rd quarter valued at $41,000. USA Financial Formulas purchased a new stake in PACS Group during the 3rd quarter valued at $46,000. KBC Group NV bought a new stake in PACS Group in the 1st quarter worth $42,000. Finally, Western Wealth Management LLC bought a new stake in PACS Group in the 1st quarter worth $48,000.

PACS Group Company Profile

PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.

The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.